Yvonne Paul
Diabetes is one of the most emerging diseases, which is becoming very common nowadays. Patients with high blood sugar will experience polyuria (frequent urination), meeting thirsty (polydipsia) and hungry (polyphagia). With the change in life style; our endocrine system of the body is getting disturbed. In order to get innovative, the Diabetes Metabolism Conference will focus on the latest and exciting innovations in all areas of diabetes and metabolism based research offering a unique opportunity for international explorers to assemble, network, talk and grasp new scientific innovations and ideas to prevent diabetes related ailments. To allocate advance researches, developments, druggists, scientists, technology challenges and improvement and alternative therapies, this meeting forms an excellent learning. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has reached to $48.5 billion. The largest segment of the market, insulin products, is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion in which was proposed for $11.3. The fastest-growing segment of oral diabetic complication of hypoglycemia drugs manufacturing funding is $14.13 in present scenario of diabetes market.
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi